HomeComparePEARW vs VYM

PEARW vs VYM: Dividend Comparison 2026

PEARW yields 33898.31% · VYM yields 2.41%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEARW wins by $9.963396520724352e+21M in total portfolio value
10 years
PEARW
PEARW
● Live price
33898.31%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.963396520724352e+21M
Annual income
$9,905,911,559,981,649,000,000,000,000.00
Full PEARW calculator →
VYM
Vanguard High Dividend Yield ETF
● Live price
2.41%
Share price
$145.48
Annual div
$3.51
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.8K
Annual income
$278.55
Full VYM calculator →

Portfolio growth — PEARW vs VYM

📍 PEARW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPEARWVYM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PEARW + VYM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PEARW pays
VYM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PEARW
Annual income on $10K today (after 15% tax)
$2,881,355.93/yr
After 10yr DRIP, annual income (after tax)
$8,420,024,825,984,401,000,000,000,000.00/yr
VYM
Annual income on $10K today (after 15% tax)
$205.23/yr
After 10yr DRIP, annual income (after tax)
$236.77/yr
At 15% tax rate, PEARW beats the other by $8,420,024,825,984,401,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PEARW + VYM for your $10,000?

PEARW: 50%VYM: 50%
100% VYM50/50100% PEARW
Portfolio after 10yr
$4.981698260362176e+21M
Annual income
$4,952,955,779,990,824,000,000,000,000.00/yr
Blended yield
99.42%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PEARW buys
0
VYM buys
0
No recent congressional trades found for PEARW or VYM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPEARWVYM
Forward yield33898.31%2.41%
Annual dividend / share$2.00$3.51
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$9.963396520724352e+21M$27.8K
Annual income after 10y$9,905,911,559,981,649,000,000,000,000.00$278.55
Total dividends collected$9.959616773768018e+21M$2.6K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: PEARW vs VYM ($10,000, DRIP)

YearPEARW PortfolioPEARW Income/yrVYM PortfolioVYM Income/yrGap
1← crossover$3,400,531$3,389,830.51$11,151$241.44+$3.39MPEARW
2$1,080,949,041$1,077,310,473.14$12,413$246.79+$1080.94MPEARW
3$321,205,007,173$320,048,391,699.27$13,794$251.79+$321204.99MPEARW
4$89,224,694,578,678$88,881,005,221,002.70$15,306$256.47+$89224694.56MPEARW
5$23,169,738,996,241,900$23,074,268,573,042,710.00$16,960$260.84+$23169738996.22MPEARW
6$5,624,691,175,493,529,000$5,599,899,554,767,550,000.00$18,768$264.92+$5624691175493.51MPEARW
7$1,276,516,462,323,700,300,000$1,270,498,042,765,922,300,000.00$20,745$268.71+$1276516462323700.25MPEARW
8$270,840,549,707,403,520,000,000$269,474,677,092,717,130,000,000.00$22,905$272.24+$270840549707403520.00MPEARW
9$53,724,262,376,359,350,000,000,000$53,434,462,988,172,430,000,000,000.00$25,265$275.51+$53724262376359346176.00MPEARW
10$9,963,396,520,724,353,000,000,000,000$9,905,911,559,981,649,000,000,000,000.00$27,842$278.55+$9.963396520724352e+21MPEARW

PEARW vs VYM: Complete Analysis 2026

PEARWStock

Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.

Full PEARW Calculator →

VYMETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →
📬

Get this PEARW vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PEARW vs SCHDPEARW vs JEPIPEARW vs OPEARW vs KOPEARW vs MAINPEARW vs VIGPEARW vs DGROPEARW vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.